The synergistic effect of co-inhibiting p110 and AKT isoforms may reflect incomplete inhibition of each part of a linear PI3K-AKT pathways, but it is also consistent with previous studies showing AKT-independent functions for PI3K [79] and PI3K-independent AKT roles in cancer [80]. The gene discussed is PIK3CB; the disease is cancer.